Identification of Admission High Risk Elderly

Stroke Clinical Trial

Official title:

Identification of Admission High Risk Elderly From Multiple Cohorts: a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01934426
• Other study ID #: 201303058RINC
• Status: Completed
• Phase: N/A
• First received: August 26, 2013
• Last updated: April 22, 2014
• Start date: April 2013
• Est. completion date: April 2014

Study information

• Verified date: April 2014
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Objective: The study aim to establish high risk admission model and readmission model for elderly in Taiwan.

Method: Investigators compare the clinical, epidemiological, and socioeconomic characteristics of admitted patients during 1 August,2011 to 31 July,2012. All patients will follow up to end of study to identify 14 days readmission and 30 days readmission to geriatic ward.

Expected Outcomes: (1) To compare the prediction value of derivation cohort and validation cohort. (2) To identify high risk indicators of admission and readmission for elderly. (3) To determine the risk factors in admission elderly association with quality indicators.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 760
• Est. completion date: April 2014
• Est. primary completion date: February 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

1. Patients with age 65 year old above

2. Patients admission to geriatric ward

Exclusion Criteria:

1. Patients with unstable vital sign

2. Patients or dependants reject to sign inform consent.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pneumonia
• Stroke
• Urinary Tract Infection
• Urinary Tract Infections

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Determine percentages of high risk in elderly 14 days readmission to geriatric ward	Readmission in 14 days to geriatric ward is an important issue of elderly.	1-year	No